Cell-based versus isolated target screening: how lucky do you feel?
Moore
K
K
Receptor and Enzyme Screening Technologies, Department of In Vitro Pharmacology, GlaxoSmithKline, Stevenage, United Kingdom. KJM83678@glaxowellcome.co.uk
Rees
S
S
D002460:Cell Line; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D006801:Humans; D020128:Inhibitory Concentration 50; D011485:Protein Binding; D012984:Software